Response is the ultimate biomarker
Personalized cancer care. For everyone. Everywhere.
A pioneer in functional precision medicine shaping the future of cancer care.
By turning complex tumor biological response into actionable insights, we transform cancer treatment at scale.
Our technology delivers rapid, personalized treatment intelligence directly from patient-derived biopsies, with applications spanning drug development and clinical decision-making.
Scalable
Rapid
End-to-End
Patient-centric
Cancer-agnostic
Technology
From biopsy to decision in under a week.
Built on breakthrough research from Ecole Polytechnique and Institut Pasteur, our platform combines miniaturized tumor-on-chip technology with AI-driven imaging to uncover personalized drug response patterns. At a time when 50% of first-line treatments fail, we enable clinicians and drug developers to find the most effective therapy for every patient.
Only 50 cells needed
Latest News
Okomera appoints Marion Ghibaudo as Chief Technology Officer
Okomera strengthens its leadership team with the appointment of Marion Ghibaudo as Chief Technology Officer. An expert in scaling medical innovations, Marion joins Okomera as the company advances toward industrial deployment.
September 16, 2026
Proud of Our Supporters
Contact Us
Get in touch!
We look forward to connecting with you.